Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Current Medical Research and Opinion|August 19, 2007
Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trialsLionel Pinto, Zhimei Liu, Quan Doan, et al.Health Economics|October 15, 2013
Heterogeneity in action: the role of passive personalization in comparative effectiveness researchAnirban Basu, Anupam B Jena, Dana P Goldman, et al.Revue Medicale Suisse|September 2, 2024
[Therapeutic endoscopic ultrasound: an innovative technique, revolutionizing our practice]Margaux Robert-Dubois, Sébastien Godat, Sarra Oumrani, et al.The American Journal of Managed Care|November 1, 2017
What do pharmaceuticals really cost in the long run?Darius Lakdawalla, Joanna P MacEwan, Robert Dubois, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Concerns Around Budget Impact Thresholds: Not All Drugs Are the SameMichael Ciarametaro, Susan Abedi, Adam Sohn, et al.Journal of Managed Care & Specialty Pharmacy|August 3, 2015
Improving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion test Assessment Tool (CAT)William J Canestaro, Daryl E Pritchard, Louis P Garrison, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical ProceduresJames Chambers, Elle Pope, Kathy Bungay, et al.Revue Medicale Suisse|June 14, 2023
[Management of acute cholecystitis]Djana Rrupa, Margaux Robert-Dubois, Emilie Uldry, et al.Hemodialysis International. International Symposium on Home Hemodialysis|January 31, 2006
Mortality differences among organisms causing septicemia in hemodialysis patientsMark D Danese, Robert I Griffiths, Michelle Dylan, et al.Journal of Comparative Effectiveness Research|November 19, 2013
The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a modelNirupama D Mitikiri, Emily S Reese, Arif Hussain, et al.Pageof 3